TITLE

Drug resistance reversed by silencing LIM domain-containing protein 1 expression in colorectal carcinoma

AUTHOR(S)
ZHANGXING CHEN; XIAOSAN ZHU; TAO XIE; JUNPEI XIE; KONG QUO; XIANG LIU
PUB. DATE
August 2014
SOURCE
Oncology Letters;2014, Vol. 8 Issue 2, p795
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The role of LIM domain-containing protein 1 (LIMD1) in the multidrug resistance of colorectal carcinoma (CRC) has not yet been established. The aim of the current study was to investigate the chemosensitivity of CRC multidrug-resistant (MDR) cells following the silencing of LIMD1. The MDR phenotypic Colo205 and HCT-8 cell lines were examined, which were established by exposure to increasing doses of 5-fluorouracil (5-FU) over a period of one year. LIMD1 siRNA constructs were transfected into CRC MDR cells and the phenotypic effects were determined comprehensively. The Colo205 and HCT-8 cell lines were more resistant to 5-FU compared with their respective parental cell lines. In addition, the two MDR cell types expressed significantly more LIMD1 compared with their parental lines. The stably transfected cells showed various degrees of reversal of the MDR phenotype, and 5-FU-induced apoptosis was increased in the transfected cells compared with the controls. In conclusion, RNA interference targeting LIMD1 may present a novel therapeutic option for CRC.
ACCESSION #
110397814

 

Related Articles

  • MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Pei-Long Li; Xin Zhang; Li-Li Wang; Lu-Tao Du; Yong-Mei Yang; Juan Li; Chuan-Xin Wang // Carcinogenesis;Dec2015, Vol. 36 Issue 12, p1484 

    One major reason for the failure of advanced colorectal cancer (CRC) treatment is the occurrence of chemoresistance to fluoropyrimidine (FU)-based chemotherapy. Various reports showed that ectopic expression and function of microRNAs (miRNAs) played key roles to mediate apoptosis at the...

  • CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil. Yamamoto, Naoyuki; Yokoyama, Shozo; Ieda, Junji; Mitani, Yasuyuki; Yamaguchi, Shunsuke; Takifuji, Katsunari; Hotta, Tsukasa; Matsuda, Kenji; Watanabe, Takashi; Shively, John; Yamaue, Hiroki // Cancer Chemotherapy & Pharmacology;Feb2015, Vol. 75 Issue 2, p421 

    Purpose: Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) re-expressed and promoted hollow spheroid (HS) formation beyond the invasion front of colorectal cancer. The aim of the present study was to clarify whether CEACAM1 cytoplasmic domain isoform balance and HS are...

  • Hepatic arterial infusion in colorectal carcinoma: is anatomical targeting still relevant in an era of molecularly targeted therapy? Melichar, Bohuslav // Biomedical Papers of the Medical Faculty of Palacky University i;Jun2012, Vol. 156 Issue 2, p81 

    Background. Historically, metastatic colorectal carcinoma was regarded as a tumor that is relatively resistant to cytotoxic agents. Due to the limited number of treatment options, methods have been investigated to enhance selectivity. One method for enhancing selectivity is anatomical targeting,...

  • Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression. Osamu Kikuchi; Shinya Ohashi; Yukie Nakai; Shunsaku Nakagawa; Kazuaki Matsuoka; Takashi Kobunai; Teiji Takechi; Yusuke Amanuma; Masahiro Yoshioka; Tomomi Ida; Yoshihiro Yamamoto; Yasushi Okuno; Shin'ichi Miyamoto; Hiroshi Nakagawa; Kazuo Matsubara; Tsutomu Chiba; Manabu Muto // American Journal of Cancer Research;2015, Vol. 5 Issue 8, p2431 

    5-Fluorouracil (5-FU) is a key drug for the treatment of esophageal squamous cell carcinoma (ESCC); however, resistance to it remains a critical limitation to its clinical use. To clarify the mechanisms of 5-FU resistance of ESCC, we originally established 5-FU-resistant ESCC cells, TE-5R, by...

  • Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer. Hsu, Hung-Chih; Liu, Yi-Shiuan; Tseng, Kai-Chi; Hsu, Cheng-Lung; Liang, Ying; Yang, Tsai-Sheng; Chen, Jinn-Shiun; Tang, Rei-Ping; Chen, Shu-Jen; Chen, Hua-Chien // International Journal of Colorectal Disease;Nov2013, Vol. 28 Issue 11, p1535 

    Background: The leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) is an adult intestinal stem cell marker frequently detected in human colorectal cancers (CRCs). However, the value of Lgr5 level in CRC prognosis and treatment prediction has not been well characterized. Methods:...

  • High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs. D¿Angelo, Daniela; Mussnich, Paula; Rosa, Roberta; Bianco, Roberto; Tortora, Giampaolo; Fusco, Alfredo // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Development of resistance to conventional drugs and novel biological agents often impair long-term chemotherapy. HMGA gene overexpression is often associated with antineoplastic drug resistance and reduced survival. Inhibition of HMGA expression in thyroid cancer cells reduces levels...

  • Expression of HAX-1 in colorectal cancer and its role in cancer cell growth. XIAOLAN LI; JIANWU JIANG; RUI YANG; XIANGSHANG XU; FAYONG HU; ANDING LIU; DEDING TAO; YAN LENG; JUNBO HU; JIANPING GONG; XUELAI LUO // Molecular Medicine Reports;2015, Vol. 12 Issue 3, p4071 

    Colorectal cancer (CRC) is one of the most common types of cancer worldwide. Hematopoietic cell-specific protein 1-associated protein X-1 (HAX-1) has been found to be involved in several types of cancer. However, the role of HAX-1 in CRC remains to be elucidated. The aim of the present study was...

  • Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo. He, Jinxia; Xie, Ganfeng; Tong, Jingtao; Peng, Yonghai; Huang, Haihui; Li, Jianjun; Wang, Ning; Liang, Houjie // Cell Biochemistry & Biophysics;Nov2014, Vol. 70 Issue 2, p1343 

    5-Fluorouracil (5-FU) is one of the most commonly used anticancer drugs in the treatment of colon cancer. However, acquired chemoresistance is becoming one of the major challenges for patients with advanced stages of colon cancer. Currently, the mechanisms underlying cancer cell resistance to...

  • Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and Its Possible Relation with the 5-Fluorouracil Drug Response. Calascibetta, A.; Contino, Flavia; Feo, S.; Gulotta, G.; Cajozzo, M.; Antona, A.; Sanguedolce, G.; Sanguedolce, R. // Journal of Nucleic Acids;2010, p1 

    Thymidylate synthase (TS) catalyzes methylation of dUMP to dTMP and it is the target for the 5-Fluorouracil (5-FU) activity. Barbour et al. showed that variant structural forms of TS in tumour cell lines confer resistance to fluoropyrimidines. We planned to perform the whole TS gene structure by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics